354 related articles for article (PubMed ID: 17480015)
1. Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra.
Quesada A; Romeo HE; Micevych P
J Comp Neurol; 2007 Jul; 503(1):198-208. PubMed ID: 17480015
[TBL] [Abstract][Full Text] [Related]
2. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.
Quesada A; Micevych PE
J Neurosci Res; 2004 Jan; 75(1):107-16. PubMed ID: 14689453
[TBL] [Abstract][Full Text] [Related]
3. PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease.
Quesada A; Lee BY; Micevych PE
Dev Neurobiol; 2008 Apr; 68(5):632-44. PubMed ID: 18278798
[TBL] [Abstract][Full Text] [Related]
4. Estrogen enhances the number of nigral dopaminergic neurons of adult male mice without affecting nigral neuroglial number and morphology.
Tripanichkul W; Jaroensuppaperch EO; Finkelstein DI
Neurosci Lett; 2008 Apr; 435(3):210-4. PubMed ID: 18358608
[TBL] [Abstract][Full Text] [Related]
5. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
[TBL] [Abstract][Full Text] [Related]
6. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
Tripanichkul W; Sripanichkulchai K; Finkelstein DI
Brain Res; 2006 Apr; 1084(1):28-37. PubMed ID: 16564034
[TBL] [Abstract][Full Text] [Related]
7. Estrogen modulation of calretinin and BDNF expression in midbrain dopaminergic neurons of ovariectomised mice.
Yi H; Bao X; Tang X; Fan X; Xu H
J Chem Neuroanat; 2016 Nov; 77():60-67. PubMed ID: 27211874
[TBL] [Abstract][Full Text] [Related]
8. GPER and IGF-1R mediate the anti-inflammatory effect of genistein against lipopolysaccharide (LPS)-induced nigrostriatal injury in rats.
Du ZR; Gu Y; Xie XM; Zhang M; Jiang GY; Chen WF
J Steroid Biochem Mol Biol; 2021 Nov; 214():105989. PubMed ID: 34478828
[TBL] [Abstract][Full Text] [Related]
9. S-100 beta and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro.
Liu JP; Lauder JM
J Neurosci Res; 1992 Oct; 33(2):248-56. PubMed ID: 1360544
[TBL] [Abstract][Full Text] [Related]
10. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in androgen and estrogen receptor expression in rat substantia nigra during development: an immunohistochemical study.
Ravizza T; Galanopoulou AS; Velísková J; Moshé SL
Neuroscience; 2002; 115(3):685-96. PubMed ID: 12435407
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
13. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
14. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons.
Chadi G; Cao Y; Pettersson RF; Fuxe K
Neuroscience; 1994 Aug; 61(4):891-910. PubMed ID: 7838386
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
[TBL] [Abstract][Full Text] [Related]
16. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
Gomide V; Bibancos T; Chadi G
Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
[TBL] [Abstract][Full Text] [Related]
17. Induction of c-Jun and suppression of CREB transcription factor proteins in axotomized neurons of substantia nigra and covariation with tyrosine hydroxylase.
Brecht S; Gass P; Anton F; Bravo R; Zimmermann M; Herdegen T
Mol Cell Neurosci; 1994 Oct; 5(5):431-41. PubMed ID: 7820366
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
19. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra.
Chu Y; Kompoliti K; Cochran EJ; Mufson EJ; Kordower JH
J Comp Neurol; 2002 Aug; 450(3):203-14. PubMed ID: 12209851
[TBL] [Abstract][Full Text] [Related]
20. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
